Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis

被引：3
|
作者：
Bond, A
Corlett, L
Nagvekar, N
Jacobson, L
Pantic, N
Beeson, D
Nicolle, M
Vincent, A
NewsomDavis, J
Spack, E
Willcox, N
机构：
[1] JOHN RADCLIFFE HOSP,INST MOL MED,NEUROSCI GRP,OXFORD OX3 9DU,ENGLAND
[2] ANERGEN,DEPT IMMUNOL,REDWOOD CITY,CA 94063
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 1997年 / 25卷 / 02期
关键词：
D O I：
10.1042/bst0250665
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：665 / 670
页数：6
相关论文
共 50 条
  • [41] ACETYLCHOLINE RECEPTOR-REACTIVE T-CELLS IN MYASTHENIA-GRAVIS - EVIDENCE FOR THE INVOLVEMENT OF DIFFERENT SUBPOPULATIONS OF T-HELPER CELLS
    YI, Q
    AHLBERG, R
    PIRSKANEN, R
    LEFVERT, AK
    JOURNAL OF NEUROIMMUNOLOGY, 1994, 50 (02) : 177 - 186
  • [42] Antigen-specific immunotherapy in myasthenia gravis: failed promise and new hope
    Pachner, AR
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 152 (1-2) : VII - VIII
  • [43] Functional defect in regulatory T cells in myasthenia gravis
    Thiruppathi, Muthusamy
    Rowin, Julie
    Jiang, Qin Li
    Sheng, Jian Rong
    Prabhakar, Bellur S.
    Meriggioli, Matthew N.
    MYASTHENIA GRAVIS AND RELATED DISORDERS I, 2012, 1274 : 68 - 76
  • [44] Regulatory T cells in multiple sclerosis and myasthenia gravis
    Danikowski, K. M.
    Jayaraman, S.
    Prabhakar, B. S.
    JOURNAL OF NEUROINFLAMMATION, 2017, 14
  • [45] SUPPRESSOR-T CELLS IN MYASTHENIA-GRAVIS
    CLEMENTI, F
    GOTTI, C
    MORI, L
    RICCIARDICASTAGNOLI, P
    MONOGRAPHS IN ALLERGY, 1988, 25 : 41 - 49
  • [46] Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis?
    Kupersmith, MJ
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2003, 23 (04) : 249 - 250
  • [47] DETECTION OF ALPHA-SUBUNIT ISOFORMS IN HUMAN MUSCLE ACETYLCHOLINE-RECEPTOR BY SPECIFIC T-CELLS FROM A MYASTHENIA-GRAVIS PATIENT
    HARCOURT, G
    BATOCCHI, AP
    HAWKE, S
    BEESON, D
    PANTIC, N
    JACOBSON, L
    WILLCOX, N
    VINCENT, A
    NEWSOMDAVIS, J
    PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1993, 254 (1339) : 1 - 6
  • [48] ANTIGEN PRESENTATION BY THYMOMA EPITHELIAL-CELLS FROM MYASTHENIA-GRAVIS PATIENTS TO POTENTIALLY PATHOGENIC T-CELLS
    GILHUS, NE
    WILLCOX, N
    HARCOURT, G
    NAGVEKAR, N
    BEESON, D
    VINCENT, A
    NEWSOMDAVIS, J
    JOURNAL OF NEUROIMMUNOLOGY, 1995, 56 (01) : 65 - 76
  • [49] Use of peptide: HLA class II complexes to study specific T cells in myasthenia gravis
    Kishore, U
    Zhang, W
    Corlett, L
    Kelleher, A
    Shiono, H
    Willcox, N
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02): : 229 - 229
  • [50] CHIMERIC AUTOANTIBODY RECEPTOR T CELLS: ANTIGEN-SPECIFIC TREATMENT OF EXPERIMENTAL MYASTHENIA GRAVIS
    Borges, Lucia S.
    Mir, Hafsa
    Nunez-Cruz, Selene
    Tong, Olivia C.
    Oh, Sangwook
    Payne, Aimee S.
    Milone, Michael C.
    Richman, David P.
    MUSCLE & NERVE, 2022, 65 : S37 - S38
12345